Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Briefing
  • Published:

A creatine kinase inhibitor targeting a redox-regulated cysteine

Creatine kinases (CKs) have emerged as a metabolic liability in many rapidly proliferating cancers. We have developed a class of covalent inhibitors that impair creatine phosphagen energetics by targeting a redox-regulated cysteine residue in the active site of CKs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Deep chemoproteomics identifies CKis as selective inhibitors of CK.

References

  1. Fenouille, N. et al. The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia. Nat. Med. 23, 301–313 (2017). An article describing CK as a vulnearbility in AML.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Loo, J. M. et al. Extracellular metabolic energetics can promote cancer progression. Cell 160, 393–406 (2015). This article describes creatine energetics as a vulnerability in liver metastases.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Maguire, O. A. et al. Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer. Cell Metab. 33, 499–512 (2021). An article describing creatine energetics as a vulnerability in breast cancers.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Xiao, H. et al. A quantitative tissue-specific landscape of protein redox regulation during aging. Cell 180, 968–983 (2020). This article describes the redox sensitivity of CK isoforms in vivo.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Darabedian, N. et al. Depletion of creatine phosphagen energetics with a covalent creatine kinase inhibitor. Nat. Chem. Bio. https://doi.org/10.1038/s41589-023-01273-x (2023).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

A creatine kinase inhibitor targeting a redox-regulated cysteine. Nat Chem Biol 19, 801–802 (2023). https://doi.org/10.1038/s41589-023-01274-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41589-023-01274-w

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research